Primary and secondary cutaneous CD30+ lymphoproliterative disorders: A report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment

Blood

Volumn 95, Issue 12, 2000, Pages 3653-3661

  Bekkenk, Marcel W ^b   Geelen, Françoise A M J ^b   Van Voorst Vader, Pieter C ^b   Heule, F ^b   Geerts, Marie Louise ^b   Van Vloten, Willem A ^b   Meijer, Chris J L M ^b   Willemze, Rein ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; RETINOID; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SKIN LYMPHOMA; TREATMENT PLANNING; TUMOR CLASSIFICATION;

EID: 0034660654     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.12.3653.012k23_3653_3661     Document Type: Article

References (34)

1. Macaulay WL. Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign-histologically malignant. Arch Dermatol. 1968; 97:23.
2. Willemze R, Meyer CJ, Van Vloten WA, Scheffer E. The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol. 1982;107: 131.
3. Kadin ME, Nasu K, Sako D, Said J. Vonderheid E. Lymphomatoid papulosis: a cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol. 1985;119:315.
4. + cutaneous lymphomas, In: van Vloten WA, ed. Cutaneous Lymphoma, Basel: Karger: 1990:132.
5. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: a proposal for classification and guidelines for management and treatment. J Am Acad Dermatol. 1993;28:973.
6. Beljaards RC, Meijer CJ, Scheffer E, et al. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin a clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol. 1989;135:1169.
7. Banerjee SS, Heald J, Harris M. Twelve cases of Ki-1 positive anaplastic large cell lymphoma of fhe skin. J Clin Pathol. 1991;44:119.
8. + anaplastic large cell lymphoma: report of 27 cases. J Cutan Pathol. 1993; 20:193.
9. Tomaszewski MM, Lupton GP, Krishnan J, May DL. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma. J Cutan Pathol. 1995;22:310.
10. + large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. Cancer. 1993;71:2097.
11. Paulli M, Berti E, Rosso R, et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin -clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol. 1995;13:1343.
12. + cutaneous lymphoproliferative disorders. Am J Surg Pathol. 1998;22:1192.
13. de Bruin PC, Beljaards RC, van Heerde P, et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-or null cell phenotype. Histopathology, 1993;23:127.
14. + lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood. 1996;87:3437.
15. Lamant L, Dastugue N, Pulford K, Delsol G. Delsol G, Mariame B. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25; p23) translocation. Blood. 1999;93:3088.
16. + lymphoma: clinico-pathological findings and outcome. Blood. 1999;93:2697.
17. ten Berge RL, Oudejans JJ, Ossenkoppele GJ, et al. ALK expression in extranodal anaplastic large cell lymphoma favors systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination J Clin Pathol. In press.
18. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361.
19. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: a progress report. Am J Clin Pathol. 1999;111:S8.
20. Demierre MF, Goldberg LJ, Kadin ME, Koh HK. Is it lymphoma or lymphomatoid papulosis? J Am Acad Dermatol. 1997;36:765.
21. Cabanillas F, Armitage J, Pugh WC, Weisenburger D, Duvic M. Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma. Ann Intern Med. 1995; 122:210.
22. Brice P, Cazals D, Mounier N, et al, for the Groupe d'Etude des Lymphomes de l'Adulte. Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Leukemia. 1998;12:213.
23. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90: 354.
24. Willemze R, Scheffer E, van Vloten WA, Meijer CJLM. Lymphomatoid papulosis and Hodgkin's disease: are they related? Arch Dermatol Res. 1983;275:159.
25. Beljaards RC, Willemze R. The prognosis of patients wilh lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol. 1992; 126:596
26. Gascoine RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999;93:3913.
27. + lymphoproliferative disorders. J Am Acad Dermatol. 1996;34:470.
28. Sanchez NP, Pittelkow MR, Muller SA, Banks PM, Winkelmann RK. The clinicopathologic spectrum of lymphomatoid papulosis: study of 31 cases. J Am Acad Dermatol. 1983;8:81.
29. El-Azhary R, Gibson LE, Kurtin PJ, Pittelkow MR, Muller SA. Lymphomatoid papulosis: a clinical and histpathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies J Am Acad Dermatol. 1994;30:210.
30. Wantzin GL, Thomsen K. PUVA-treatment in lymphomatoid papulosis. Br J Dermatol. 1982;107: 687.
31. Zirbel GM, Gellis SE, Kadin ME, Esterly NB Lymphomatoid papulosis in children. J Am Acad Dermatol. 1995;33:741.
32. Ashworth J, Paterson WD, MacKie RM. Lymphomatoid papulosis/pityriasis lichenoides in two children. Pediatr Dermatol. 1987;4:238.
33. van Doom R, van Haselen CW, van Voorst Vader PC, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol. In press.
34. Basarab S, Fraser-Andrews EA, Orchard G, Whittaker S, Russell-Jones R. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases. Br J Dermatol. 1998;139: 630.